{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:01:33Z","timestamp":1768269693618,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The End TB Strategy aims to reduce new tuberculosis (TB) cases by 90% and TB-related deaths by 95% between 2015 \u2013 2035. We determined the trend of case notification rates (CNRs) and treatment outcomes of TB cases with and without HIV co-infection in rural Uganda to provide an interim evaluation of progress towards this global target in rural settings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We extracted retrospective programmatic data on notified TB cases and treatment outcomes from 2015 \u2013 2019 for eight districts in rural Uganda from the District Health Information System 2. We estimated CNRs as the number of TB cases per 100,000 population. Treatment success rate (TSR) was calculated as the sum of TB cure and treatment completion for each year. Trends were estimated using the Mann\u2013Kendall test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 11,804\u00a0TB cases, of which 5,811 (49.2%) were HIV co-infected, were notified. The overall TB CNR increased by 3.7-fold from 37.7 to 141.3 cases per 100,000 population in 2015 and 2019 respectively. The increment was observed among people with HIV (from 204.7 to 730.2 per 100,000, <jats:italic>p<\/jats:italic>\u2009=\u20090.028) and HIV-uninfected individuals (from 19.9 to 78.7 per 100,000, <jats:italic>p<\/jats:italic>\u2009=\u20090.028).<\/jats:p>\n                <jats:p>There was a decline in the TSR among HIV-negative TB cases from 82.1% in 2015 to 63.9% in 2019 (<jats:italic>p<\/jats:italic>\u2009=\u20090.086). Conversely, there was an increase in the TSR among HIV co-infected TB cases (from 69.9% to 81.9%, <jats:italic>p<\/jats:italic>\u2009=\u20090.807).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The CNR increased among people with and without HIV while the TSR reduced among HIV-negative TB cases. There is need to refocus programs to address barriers to treatment success among HIV-negative TB cases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-13111-1","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:02:30Z","timestamp":1649142150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Trends of notification rates and treatment outcomes of tuberculosis cases with and without HIV co-infection in eight rural districts of Uganda (2015 \u2013 2019)"],"prefix":"10.1186","volume":"22","author":[{"given":"Joseph Baruch","family":"Baluku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Resty","family":"Nanyonjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolly","family":"Ayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehu Eleazer","family":"Obwalatum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Nakaweesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Senyimba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deus","family":"Lukoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Lubwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Mukasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"13111_CR1","unstructured":"World Health Organization. Global tuberculosis report 2020. In: Global tuberculosis report 2020. 2020."},{"key":"13111_CR2","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis: World Health Organization; 2016."},{"issue":"13","key":"13111_CR3","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2147\/IDR.S248875","volume":"4","author":"Z Pan","year":"2020","unstructured":"Pan Z, Zhang J, Bu Q, He H, Bai L, Yang J, et al. The Gap Between Global Tuberculosis Incidence and the First Milestone of the WHO End Tuberculosis Strategy: An Analysis Based on the Global Burden of Disease 2017 Database. Infect Drug Resist. 2020;4(13):1281\u20136.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"13111_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12199-020-00931-z","volume":"26","author":"Y Gelaw","year":"2021","unstructured":"Gelaw Y, Getaneh Z, Melku M. Anemia as a risk factor for tuberculosis: a systematic review and meta-analysis. Environ Health Prev Med. 2021;26(1):13.","journal-title":"Environ Health Prev Med"},{"issue":"8","key":"13111_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/23744235.2020.1761560","volume":"52","author":"M Boah","year":"2020","unstructured":"Boah M, Adampah T, Jin B, Wang W, Wang K. Trend of tuberculosis case notifications and their determinants in Africa and South-East Asia during 2000\u20132018: a longitudinal analysis of national data from 58 countries. Infect Dis. 2020;52(8):538\u201346.","journal-title":"Infect Dis"},{"issue":"1","key":"13111_CR6","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/s12879-019-4246-2","volume":"19","author":"A Aturinde","year":"2019","unstructured":"Aturinde A, Farnaghi M, Pilesj\u00f6 P, Mansourian A. Spatial analysis of HIV-TB co-clustering in Uganda. BMC Infect Dis. 2019;19(1):612.","journal-title":"BMC Infect Dis"},{"key":"13111_CR7","doi-asserted-by":"crossref","unstructured":"Cha J, Thwaites GE, Ashton PM. An Evaluation of Progress Towards the 2035 WHO End TB Targets in 40 High Burden Countries. medRxiv. 2020;","DOI":"10.1101\/2020.10.02.20175307"},{"key":"13111_CR8","doi-asserted-by":"crossref","unstructured":"Berger CA, Kityamuwesi A, Crowder R, Lamunu M, Kunihira Tinka L, Ggita J, et al. Variation in tuberculosis treatment outcomes and treatment supervision practices in Uganda. J Clin Tuberc Mycobact Dis. 2020 Dec 1;21:100184.","DOI":"10.1016\/j.jctube.2020.100184"},{"issue":"2","key":"13111_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.5588\/pha.16.0115","volume":"7","author":"J Musaazi","year":"2017","unstructured":"Musaazi J, Kiragga AN, Castelnuovo B, Kambugu A, Bradley J, Rehman AM. Tuberculosis treatment success among rural and urban Ugandans living with HIV: a retrospective study. Public Health Action. 2017;7(2):100\u20139.","journal-title":"Public Health Action"},{"issue":"2","key":"13111_CR10","first-page":"62","volume":"48","author":"R Dehnavieh","year":"2019","unstructured":"Dehnavieh R, Haghdoost A, Khosravi A, Hoseinabadi F, Rahimi H, Poursheikhali A, et al. The District Health Information System (DHIS2): A literature review and meta-synthesis of its strengths and operational challenges based on the experiences of 11 countries. Health Inf Manag J. 2019;48(2):62\u201375.","journal-title":"Health Inf Manag J"},{"key":"13111_CR11","volume-title":"Manual for Management and Control of Tuberculosis and Leprosy. 3rd Edition","author":"Ministry of Health","year":"2017","unstructured":"Ministry of Health. Manual for Management and Control of Tuberculosis and Leprosy. 3rd Edition. Kampala: Uganda National Tuberculosis and Leprosy Control Program; 2017."},{"key":"13111_CR12","unstructured":"World Health Organization. Definitions and reporting framework for tuberculosis\u20132013 revision. World Health Organization; 2013. Report No.: 9241505346."},{"key":"13111_CR13","unstructured":"Uganda Bureau of Statistics. Population Projections By District, 2015 to 2021 \u2013 Uganda Bureau of Statistics [Internet]. [Cited 2021 May 18]. Available from: https:\/\/www.ubos.org\/population-projections-by-district-2015-to-2021\/"},{"issue":"1","key":"13111_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12889-020-8436-z","volume":"20","author":"J Ouma","year":"2020","unstructured":"Ouma J, Jeffery C, Valadez JJ, Wanyenze RK, Todd J, Levin J. Combining national survey with facility-based HIV testing data to obtain more accurate estimate of HIV prevalence in districts in Uganda. BMC Public Health. 2020;20(1):379.","journal-title":"BMC Public Health"},{"key":"13111_CR15","unstructured":"Ministry of Health. The 2019 HIV epidemiological surveillance report for Uganda. AIDS Control Program; 2020 Mar."},{"key":"13111_CR16","first-page":"100278","volume":"25","author":"NP Mnyambwa","year":"2021","unstructured":"Mnyambwa NP, Philbert D, Kimaro G, Wandiga S, Kirenga B, Mmbaga BT, et al. Gaps related to screening and diagnosis of tuberculosis in care cascade in selected health facilities in East Africa countries: A retrospective study. J Clin Tuberc Mycobact Dis. 2021;25:100278.","journal-title":"J Clin Tuberc Mycobact Dis."},{"issue":"1","key":"13111_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12913-020-4997-x","volume":"20","author":"T Nalugwa","year":"2020","unstructured":"Nalugwa T, Shete PB, Nantale M, Farr K, Ojok C, Ochom E, et al. Challenges with scale-up of GeneXpert MTB\/RIF\u00ae in Uganda: a health systems perspective. BMC Health Serv Res. 2020;20(1):162.","journal-title":"BMC Health Serv Res"},{"key":"13111_CR18","first-page":"100099","volume":"15","author":"K Farr","year":"2019","unstructured":"Farr K, Nalugwa T, Ojok C, Nantale M, Nabwire S, Oyuku D, et al. Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB\/RIF scale-up. J Clin Tuberc Mycobact Dis. 2019;15:100099.","journal-title":"J Clin Tuberc Mycobact Dis."},{"key":"13111_CR19","doi-asserted-by":"crossref","unstructured":"Scott C. Evaluation of Automated Molecular Testing Rollout for Tuberculosis Diagnosis Using Routinely Collected Surveillance Data \u2014 Uganda, 2012\u20132015. MMWR Morb Mortal Wkly Rep [Internet]. 2017 [cited 2021 May 30];66. Available from: https:\/\/www.facebook.com\/CDCMMWR","DOI":"10.15585\/mmwr.mm6612a6"},{"issue":"5","key":"13111_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1164\/rccm.201803-0490OC","volume":"199","author":"C Yoon","year":"2019","unstructured":"Yoon C, Semitala FC, Asege L, Katende J, Mwebe S, Andama AO, et al. Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV. Am J Respir Crit Care Med. 2019;199(5):643\u201350.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"13111_CR21","doi-asserted-by":"publisher","first-page":"e01032","DOI":"10.1128\/JCM.01032-20","volume":"58","author":"A Esmail","year":"2020","unstructured":"Esmail A, Pooran A, Sabur NF, Fadul M, Brar MS, Oelofse S, et al. An optimal diagnostic strategy for tuberculosis in hospitalized HIV-infected patients using GeneXpert MTB\/RIF and Alere determine TB LAM Ag. J Clin Microbiol. 2020;58(10):e01032-e1120.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"13111_CR22","doi-asserted-by":"publisher","first-page":"e1001683","DOI":"10.1371\/journal.pmed.1001683","volume":"11","author":"J Riha","year":"2014","unstructured":"Riha J, Karabarinde A, Ssenyomo G, Allender S, Asiki G, Kamali A, et al. Urbanicity and Lifestyle Risk Factors for Cardiometabolic Diseases in Rural Uganda: A Cross-Sectional Study. PLOS Med. 2014;11(7):e1001683.","journal-title":"PLOS Med."},{"key":"13111_CR23","unstructured":"Owori M. Poverty in Uganda: National and regionaldata and trends: fact sheet [Internet]. Development initiatives; 2020 Oct. Available from: https:\/\/devinit.org\/resources\/poverty-uganda-national-and-regional-data-and-trends\/#downloads"},{"issue":"4","key":"13111_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/tmi.12451","volume":"20","author":"G Asiki","year":"2015","unstructured":"Asiki G, Baisley K, Kamali A, Kaleebu P, Seeley J, Newton R. A prospective study of trends in consumption of cigarettes and alcohol among adults in a rural Ugandan population cohort, 1994\u20132011. Trop Med Int Health. 2015;20(4):527\u201336.","journal-title":"Trop Med Int Health"},{"issue":"12","key":"13111_CR25","doi-asserted-by":"publisher","first-page":"e114225","DOI":"10.1371\/journal.pone.0114225","volume":"9","author":"MH Dangisso","year":"2014","unstructured":"Dangisso MH, Datiko DG, Lindtj\u00f8rn B. Trends of Tuberculosis Case Notification and Treatment Outcomes in the Sidama Zone, Southern Ethiopia: Ten-Year Retrospective Trend Analysis in Urban-Rural Settings. PLOS ONE. 2014;9(12):e114225.","journal-title":"PLOS ONE."},{"issue":"1","key":"13111_CR26","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1186\/s12889-017-4988-y","volume":"17","author":"E Wobudeya","year":"2017","unstructured":"Wobudeya E, Sekadde-Kasirye M, Kimuli D, Mugabe F, Lukoye D. Trend and outcome of notified children with tuberculosis during 2011\u20132015 in Kampala, Uganda. BMC Public Health. 2017;17(1):963.","journal-title":"BMC Public Health"},{"issue":"9","key":"13111_CR27","doi-asserted-by":"publisher","first-page":"e25394","DOI":"10.1002\/jia2.25394","volume":"22","author":"S Zawedde-Muyanja","year":"2019","unstructured":"Zawedde-Muyanja S, Manabe YC, Musaazi J, Mugabe FR, Ross JM, Hermans S. Anti-retroviral therapy scale-up and its impact on sex-stratified tuberculosis notification trends in Uganda. J Int AIDS Soc. 2019;22(9):e25394.","journal-title":"J Int AIDS Soc."},{"issue":"1","key":"13111_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12890-019-0853-3","volume":"19","author":"NS Kirirabwa","year":"2019","unstructured":"Kirirabwa NS, Kimuli D, Nanziri C, Sama D, Ntudhu S, Okello DA, et al. A four-year trend in pulmonary bacteriologically confirmed tuberculosis case detection in Kampala-Uganda. BMC Pulm Med. 2019;19(1):91.","journal-title":"BMC Pulm Med"},{"key":"13111_CR29","volume-title":"WHO global lists of high burden countries for tuberculosis (TB), TB\/HIV and multidrug\/rifampicin-resistant TB (MDR\/RR-TB), 2021\u20132025","author":"World Health Organisation","year":"2021","unstructured":"World Health Organisation. WHO global lists of high burden countries for tuberculosis (TB), TB\/HIV and multidrug\/rifampicin-resistant TB (MDR\/RR-TB), 2021\u20132025. Geneva: Switzerland; 2021."},{"key":"13111_CR30","volume-title":"Uganda National TB and Leprosy Annual Report 2020\/2021","author":"Ministry of Health","year":"2021","unstructured":"Ministry of Health. Uganda National TB and Leprosy Annual Report 2020\/2021. Kampala: Uganda: Ministry of Health; 2021."},{"issue":"1","key":"13111_CR31","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1186\/s12889-016-3573-0","volume":"16","author":"T Kakaire","year":"2016","unstructured":"Kakaire T, Schlech W, Coutinho A, Brough R, Parkes-Ratanshi R. The future of financing for HIV services in Uganda and the wider sub-Saharan Africa region: should we ask patients to contribute to the cost of their care? BMC Public Health. 2016;16(1):896.","journal-title":"BMC Public Health"},{"issue":"1","key":"13111_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1186\/s12913-019-4834-2","volume":"19","author":"J Izudi","year":"2019","unstructured":"Izudi J, Tamwesigire IK, Bajunirwe F. Explaining the successes and failures of tuberculosis treatment programs; a tale of two regions in rural eastern Uganda. BMC Health Serv Res. 2019;19(1):979.","journal-title":"BMC Health Serv Res."},{"issue":"1","key":"13111_CR33","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/s12879-016-1917-0","volume":"16","author":"A Asres","year":"2016","unstructured":"Asres A, Jerene D, Deressa W. Tuberculosis treatment outcomes of six and eight month treatment regimens in districts of Southwestern Ethiopia: a comparative cross-sectional study. BMC Infect Dis. 2016;16(1):653.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13111-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-13111-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13111-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:04:05Z","timestamp":1649142245000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-13111-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["13111"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-13111-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"1 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Mildmay Uganda Research and Ethics Committee (REC REF 0804\u20132018). This project was reviewed in accordance with CDC human research protection procedures and was determined to be research, but CDC investigators did not interact with human subjects or have access to identifiable data or specimens for research purposes. The data used were aggregated and individual patients could not be identified. We therefore did not seek informed consent. The Mildmay Uganda Research and Ethics Committee provided waiver of consent for the use of secondary data. Moreover, the data were readily available in the public domain (DHIS2). All methods were performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"651"}}